Revisiting the potential of natural products in antimycobacterial therapy: advances in drug discovery and semisynthetic solutions

M George, GD Wright - Current Opinion in Microbiology, 2025 - Elsevier
Natural products have been pivotal in treating mycobacterial infections with early antibiotics
such as streptomycin, forming the foundation of tuberculosis therapy. However, the …

Multifactorial genetic control and magnesium levels govern the production of a Streptomyces antibiotic with unusual cell density dependence

Hindra, MA Elliot - Msystems, 2024 - journals.asm.org
Streptomyces bacteria are renowned both for their antibiotic production capabilities and for
their cryptic metabolic potential. Their metabolic repertoire is subject to stringent genetic …

[HTML][HTML] Application of the Rumsfeld matrix to anticancer natural product target discovery

C Bailly - Pharmacological Research-Reports, 2024 - Elsevier
For a long time, natural products (NP) contribute to the treatment of human pathologies,
notably to cancer treatment with microbial and plant-derived products. The mechanism of …

Antimicrobial and antibiofilm activity of specialized metabolites isolated from Centaurea hyalolepis

S Ismail, M Masi, R Gaglione, A Arciello, A Cimmino - PeerJ, 2024 - peerj.com
The discovery of plant-derived compounds that are able to combat antibiotic-resistant
pathogens is an urgent demand. Over years, Centaurea hyalolepis attracted considerable …

[HTML][HTML] A Broad Spectrum Lasso Peptide Antibiotic Targeting the Bacterial Ribosome

G Wright, M Jangra, D Travin… - Research …, 2024 - pmc.ncbi.nlm.nih.gov
Lasso peptides, biologically active molecules with a distinct structurally constrained knotted
fold, are natural products belonging to the class of ribosomally-synthesized and …

Butyrolactol A is a phospholipid flippase inhibitor that potentiates the bioactivity of caspofungin against resistant fungi

X Chen, HD Duan, MJ Hoy, K Koteva, M Spitzer… - bioRxiv, 2025 - biorxiv.org
Fungal infections cause millions of deaths annually and are challenging to treat due to
limited antifungal options and increasing drug resistance. Cryptococci are intrinsically …

A microbial natural product fractionation library screen with HRMS/MS dereplication identifies new lipopeptaibiotics against Candida auris

G Wright, X Chen, K Koteva, S Chou, A Guitor… - 2025 - researchsquare.com
The rise of drug-resistant fungal pathogens, including Candida auris, highlights the urgent
need for novel antifungal therapies. We developed a cost-effective platform combining …

Using Biofilms to Identify Novel Antibiotics and Assess Infection Prevention Methods

V Coles - 2024 - macsphere.mcmaster.ca
As antimicrobial resistance proliferates, standard treatments for bacterial infections are
rendered ineffective. There is therefore a need to both prevent infections and develop new …

[DOC][DOC] A microbial natural product fractionation library screen with HRMS/MS dereplication identifies new lipopeptaibiotics against Candida auris

X Chen, K Koteva, S Chou, A Guitor, D Pallant, Y Lee… - assets-eu.researchsquare.com
The rise of drug-resistant fungal pathogens, including Candida auris, highlights the urgent
need for novel antifungal therapies. We developed a cost-effective platform combining …